Synthetic Genetic Targeting of Genome Instability in Cancer
Cancer is a leading cause of death throughout the World. A limitation of many current chemotherapeutic approaches is that their cytotoxic effects are not restricted to cancer cells, and adverse side effects can occur within normal tissues. Consequently, novel strategies are urgently needed to better...
Main Authors: | Kirk J. McManus, Brent J. Guppy, Babu V. Sajesh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/5/3/739 |
Similar Items
-
Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy
by: Ananna Bhadra Arna, et al.
Published: (2023-01-01) -
Synthetic Vulnerabilities in the KRAS Pathway
by: Marta Roman, et al.
Published: (2022-06-01) -
Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer
by: Laura L. Thompson, et al.
Published: (2017-11-01) -
Genomic Instability and Replicative Stress in Multiple Myeloma: The Final Curtain?
by: Oronza A. Botrugno, et al.
Published: (2021-12-01) -
Synthetic lethal approaches to target cancers with loss of PTEN function
by: Ayse Ertay, et al.
Published: (2023-11-01)